S Ennis, S Goverdhan, A Cree, J Hoh, A … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Method: Age-related macular degeneration (AMD) case–control data from a
genomewide single-nucleotide polymorphism (SNP) panel were used to identify the
target interval to be genotyped at higher density in a second independent ... Cited by 11 - Related articles - BL Direct - All 5 versions
KM Prasad, VL Nimgaonkar - Neurogenetics of Psychiatric Disorders, 2007 - books.google.com Gene-Mapping Studies for Schizophrenia: How Useful Are They for the Clinician?
Konasale M. Prasad Western Psychiatric Institute and Clinic, University of
Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA Vishwajit L. ... Cited by 2 - Related articles - BL Direct
- ►iovs.org K Mori, PL Gehlbach, S Kabasawa, I Kawasaki … - Investigative Ophthalmology & Visual Science, 2007 - ARVO PURPOSE. Ethnic variation has been reported in age-related macular degeneration
(AMD)–associated Y402H polymorphism in complement factor H (CFH). This
variation is evident in the Japanese population. Recently a strong ... Cited by 10 - Related articles - BL Direct - All 2 versions
X Luo, H Kranzler, J Lappalainen, R … - American Journal of Medical Genetics, 2004 - interscience.wiley.com Calcyon is a brain-specific D1 dopamine receptor-interacting protein, with a
potential role in D1-mediated physiological processes, including motor control,
reward mechanisms, and cognitive processes. Our objective was to ... Cited by 3 - Related articles - BL Direct - All 3 versions
- ►tsukuba.ac.jp [PDF] H Ishiguro, M Koga, Y Horiuchi, T Inada, N … - Neuroscience research, 2007 - Elsevier The protein interacting with C-kinase 1 (PICK1) has been implicated in the
susceptibility to schizophrenia. PICK1 interacts with enzymes and receptors that
play roles in the pathogenesis of schizophrenia via glutamatergic ... Cited by 4 - Related articles - All 11 versions
SH Jeong, EJ Joo, YM Ahn, YS Kim - Progress in Neuropsychopharmacology & Biological …, 2004 - Elsevier Inherited or acquired dysfunction of the dopamine system is believed to underlie
the core symptoms of schizophrenia, and there are some evidences that dopamine
transporter activity may be altered in schizophrenic patients. Therefore, ... Cited by 5 - Related articles - All 4 versions
Q Sha, X Zhu, Y Zuo, R Cooper, S Zhang - Annals of Human Genetics, 2006 - stt.msu.edu Complex diseases are presumed to be the results of the interaction of several
genes and environmental factors, with each gene only having a small effect on
the disease. Mapping complex disease genes therefore becomes one of the ... Cited by 6 - Related articles - View as HTML - BL Direct - All 5 versions
LJ Chen, DT Liu, PO Tam, WM Chan, K Liu, … - Mol Vis, 2006 - molvis.org Results: Y402H (1277 T>C) has low frequencies in our study population, 5.8% in
patients and 3.9% in controls. It was not associated with exudative AMD adjusted
for age, gender and smoking. Significant associations were detected for AMD ... Cited by 34 - Related articles - Cached - All 10 versions
B Zhang, Y Jia, Y Yuan, X Yu, Q Xu, Y Shen, … - Psychiatric Genetics, 2004 - journals.lww.com Several lines of evidence suggest that dysfunctions of neurotransmitters are
associated with schizophrenia. DOPA decarboxylase (DDC) is an enzyme involved
directly in the synthesis of dopamine and serotonin, and indirectly in the ... Cited by 8 - Related articles - BL Direct - All 2 versions
